Literature DB >> 11737556

Intracerebroventricular adrenomedullin stimulates the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system and production of hypothalamic nitric oxide.

J Shan1, T L Krukoff.   

Abstract

We tested the hypothesis that central adrenomedullin stimulates activity of the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic output from the brain, and we assessed the effects of central adrenomedullin on the nitric oxide (NO) system in the brain. In conscious rats, intracerebroventricular (i.c.v.) injections of adrenomedullin (2 nmol/kg) increased arterial pressure and heart rate, with return to baseline values within 20 min and 65 min of injections, respectively. Adrenomedullin injections augmented expression of tyrosine hydroxylase mRNA in the locus coeruleus after 4 h. Plasma concentrations of adrenocorticotropic hormone, measured with radioimmunoassay, were also increased by adrenomedullin. i.c.v. Adrenomedullin stimulated Fos expression in neurones within autonomic centres including the paraventricular nucleus (PVN) of the hypothalamus, arcuate nucleus, locus coeruleus, nucleus of the tractus solitarius and area postrema. In the PVN, large proportions of corticotropin releasing factor- and NO-producing neurones were activated (Fos positive). NO production, measured with nitrate/nitrite assays, was elevated in the hypothalamus, but not brainstem, of adrenomedullin-treated rats compared to controls. We conclude that centrally administered adrenomedullin stimulates activity of the HPA axis, the sympathetic nervous system, and the hypothalamic NO system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737556     DOI: 10.1046/j.1365-2826.2001.00721.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  8 in total

1.  Adrenomedullin in the rostral ventrolateral medulla inhibits baroreflex control of heart rate: a role for protein kinase A.

Authors:  Yong Xu; Teresa L Krukoff
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

2.  Adrenomedullin in the rostral ventrolateral medulla increases arterial pressure and heart rate: roles of glutamate and nitric oxide.

Authors:  Yong Xu; Teresa L Krukoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-06-03       Impact factor: 3.619

3.  Decrease in arterial pressure induced by adrenomedullin in the hypothalamic paraventricular nucleus is mediated by nitric oxide and GABA.

Authors:  Yong Xu; Teresa L Krukoff
Journal:  Regul Pept       Date:  2004-06-15

4.  Function and pharmacology of spinally-projecting sympathetic pre-autonomic neurones in the paraventricular nucleus of the hypothalamus.

Authors:  Nicolas Nunn; Matthew Womack; Caroline Dart; Richard Barrett-Jolley
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

5.  Cardiovascular effects of the intracerebroventricular injection of adrenomedullin: roles of the peripheral vasopressin and central cholinergic systems.

Authors:  B Cam-Etoz; N Isbil-Buyukcoskun; K Ozluk
Journal:  Braz J Med Biol Res       Date:  2012-03-01       Impact factor: 2.590

6.  Altered Arginine/Nitric Oxide Pathway in Children Diagnosed Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment.

Authors:  Ebru Doneray; Kemal Utku Yazici; Ipek Percinel Yazici; Bilal Ustundag
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

7.  Adrenomedullin as a growth and cell fate regulatory factor for adult neural stem cells.

Authors:  Sonia Martínez-Herrero; Ignacio M Larráyoz; Laura Ochoa-Callejero; Josune García-Sanmartín; Alfredo Martínez
Journal:  Stem Cells Int       Date:  2012-09-24       Impact factor: 5.443

Review 8.  Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.

Authors:  Tayla A Rees; Erica R Hendrikse; Debbie L Hay; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2021-07-27       Impact factor: 9.473

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.